RESUMEN

PURPOSE: To investigate safety and performance aspects of parallel-transmit (pTx) RF control-modes for a body coil at B 0 ≤ 3 T $$ {B}_0\le 3\mathrm{T} $$ . METHODS: Electromagnetic simulations of 11 human voxel models in cardiac imaging position were conducted for B 0 = 0.5 T $$ {B}_0=0.5\mathrm{T} $$ , 1.5 T $$ 1.5\mathrm{T} $$ and 3 T $$ 3\mathrm{T} $$ and a body coil with a configurable number of transmit channels (1, 2, 4, 8, 16). Three safety modes were considered: the 'SAR-controlled mode' (SCM), where specific absorption rate (SAR) is limited directly, a 'phase agnostic SAR-controlled mode' (PASCM), where phase information is neglected, and a 'power-controlled mode' (PCM), where the voltage amplitude for each channel is limited. For either mode, safety limits were established based on a set of 'anchor' simulations and then evaluated in 'target' simulations on previously unseen models. The comparison allowed to derive safety factors accounting for varying patient anatomies. All control modes were compared in terms of the B 1 + $$ {B}_1^{+} $$ amplitude and homogeneity they permit under their respective safety requirements. RESULTS: Large safety factors (approximately five) are needed if only one or two anchor models are investigated but they shrink with increasing number of anchors. The achievable B 1 + $$ {B}_1^{+} $$ is highest for SCM but this advantage is reduced when the safety factor is included. PCM appears to be more robust against variations of subjects. PASCM performance is mostly in between SCM and PCM. Compared to standard circularly polarized (CP) excitation, pTx offers minor B 1 + $$ {B}_1^{+} $$ improvements if local SAR limits are always enforced. CONCLUSION: PTx body coils can safely be used at B 0 ≤ 3 T $$ {B}_0\le 3\mathrm{T} $$ . Uncertainties in patient anatomy must be accounted for, however, by simulating many models.

Asunto(s)

RESUMEN

The subject of localization has received great deal attention in the past decades. Although it is perhaps a well-studied problem, there is still room for improvement. Traditional localization methods usually assume the number of sensors is sufficient for providing desired performance. However, this assumption is not always satisfied in practice. This paper studies the time of arrival (TOA)-based source positioning in the presence of sensor position errors. An error refined solution is developed for reducing the mean-squared-error (MSE) and bias in small sensor network (the number of sensors is fewer) when the noise or error level is relatively large. The MSE performance is analyzed theoretically and validated by simulations. Analytical and numerical results show the proposed method attains the Cramér-Rao lower bound (CRLB). It outperforms the existing closed-form methods with slightly raising computation complexity, especially in the larger noise/error case.

RESUMEN

A constrained least-squares (CLS) 3D source localization method is presented for acoustic sensor networks with sensor position errors. The proposed approach uses angles of arrivals (AOAs) and gain ratios of arrival (GROAs) measured simultaneously at each node to estimate the source position jointly. Compared to AOA-only localization methods, the GROAs can be used in conjunction with AOA measurements so as to get more accurate results by exploiting the geometrical relationship between these two measurements. Compared to time difference of arrival localization methods, the proposed algorithm does not require accurate time synchronization over different nodes. The theoretical mean-square error matrices of the proposed approach are derived and they are exactly equal to the Cramér-Rao bound for Gaussian noise under the small error condition. Simulations validate the performance of the proposed estimator.

RESUMEN

PURPOSE: Skin surface dosimetric discrepancies between measured and treatment planning system predicted values were traced to source position sag inside the applicator and to source transit time. We quantified their dosimetric impact and propose corrections for clinical use. METHODS AND MATERIALS: We measured the dose profiles from the Varian Leipzig-style high-dose-rate (HDR) skin applicator, using EBT3 film, photon diode, and optically stimulated luminescence dosimeter for three different GammaMedplus HDR afterloaders. The measured dose profiles at several depths were compared with BrachyVision Acuros calculated profiles. To assess the impact of the source sag, two different applicator orientations were considered. The dose contribution during source transit was assessed by comparing diode measurements using an HDR timer and an electrometer timer. RESULTS: Depth doses measured using the three dosimeters were in good agreement, but were consistently higher than the Acuros dose calculations. Measurements with the applicator face up were significantly (exceeding 10%) lower than those in the face down position, due to source sag inside the applicator. Based on the inverse square law, the effective source sag was evaluated to be about 0.5 mm from the planned position. The additional dose during source transit was evaluated to be about 2.8% for 30 seconds of treatment with a 40700 U (10 Ci) source. CONCLUSION: With a very short source-to-surface distance, the small source sag inside the applicator has a significant dosimetric impact. This effect is unaccounted for in the vendor's treatment planning template and should be considered before the clinical use of the applicator. Further investigation of other applicators with large source lumen diameter may be warranted.

Asunto(s)